Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes

ConclusionsThe digital ID tool accurately matches NCCN criteria in one-to-one fashion to identify at-risk individuals for HCS and may be useful in clinical practice, specifically for BRCA-related HBOC and Lynch Syndrome.

Source: Hereditary Cancer in Clinical Practice - January 11, 2019 Category: Cancer & Oncology Source Type: research